[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Ozmosi [@OzmosiHealth](/creator/twitter/OzmosiHealth) on x 2638 followers Created: 2025-07-24 13:32:29 UTC $IDYA IDEAYA Biosciences to present Phase X Clinical Trial of Neoadjuvant Darovasertib at ESMO 2025 for Primary Uveal Melanoma. More Info: $XBI $IBB $XPH $PPH  XXX engagements  **Related Topics** [$pph](/topic/$pph) [$xph](/topic/$xph) [$ibb](/topic/$ibb) [$xbi](/topic/$xbi) [more info](/topic/more-info) [$idya](/topic/$idya) [Post Link](https://x.com/OzmosiHealth/status/1948375737167409474)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Ozmosi @OzmosiHealth on x 2638 followers
Created: 2025-07-24 13:32:29 UTC
$IDYA IDEAYA Biosciences to present Phase X Clinical Trial of Neoadjuvant Darovasertib at ESMO 2025 for Primary Uveal Melanoma.
More Info: $XBI $IBB $XPH $PPH
XXX engagements
/post/tweet::1948375737167409474